zepbound or tirzepatide FDA approval for (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Tirzepatide (Zepbound) Ohio: JourneyLite Prescription

Description

Retatrutide is a novel triple-agonist peptide developed by Eli Lilly that simultaneously activates three metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors

Lean proteins (chicken breast, fish, tofu), complex carbohydrates (oatmeal, sweet potato, brown rice), and plenty of vegetables provide steady energy without overwhelming your digestive system

In addition to above mentioned properties, GLP-1 RAs have an antiinflammatory effect

d Body mass index was calculated as weight in kilograms divided by height in meters squared

Serving Madison & Dane County Our clinic is conveniently located in Madison and serves patients from: Madison Monona Fitchburg Middleton Sun Prairie Verona McFarland Many patients throughout Dane County visit our clinic for medically supervised GLP-1 weight loss programs